Correlation Between Evoke Pharma and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evoke Pharma and Citius Oncology,, you can compare the effects of market volatilities on Evoke Pharma and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Citius Oncology,.
Diversification Opportunities for Evoke Pharma and Citius Oncology,
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Evoke and Citius is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Citius Oncology, go up and down completely randomly.
Pair Corralation between Evoke Pharma and Citius Oncology,
Given the investment horizon of 90 days Evoke Pharma is expected to generate 0.42 times more return on investment than Citius Oncology,. However, Evoke Pharma is 2.37 times less risky than Citius Oncology,. It trades about -0.05 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.15 per unit of risk. If you would invest 2,040 in Evoke Pharma on September 12, 2024 and sell it today you would lose (1,632) from holding Evoke Pharma or give up 80.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 24.15% |
| Values | Daily Returns |
Evoke Pharma vs. Citius Oncology,
Performance |
| Timeline |
| Evoke Pharma |
| Citius Oncology, |
Evoke Pharma and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evoke Pharma and Citius Oncology,
The main advantage of trading using opposite Evoke Pharma and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Evoke Pharma vs. Petros Pharmaceuticals | Evoke Pharma vs. Cumberland Pharmaceuticals | Evoke Pharma vs. Painreform | Evoke Pharma vs. Aquestive Therapeutics |
| Citius Oncology, vs. Evoke Pharma | Citius Oncology, vs. Dynavax Technologies | Citius Oncology, vs. Amphastar P | Citius Oncology, vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |